Ronald Hafner is Chairman of the board of NLS Pharma since its inception in August 2015. Until recently, he was Chief Executive Officer of Infosys Lodestone. Prior to Lodestone’s acquisition by Infosys in 2012, Ronald was Chief Executive Officer and Partner of Lodestone Management Consultants AG. He was responsible for the company’s global operations since founding the business in 2005. Prior to becoming Partner at PriceWaterhouseCoopers, he was involved in strategy consulting at McKinsey in Zurich. Ronald has a master’s degree in economics and business administration from the University of Basel/Switzerland.